Not a good buy right now for an impatient entry: momentum is weakening (MACD negative and expanding) and price is breaking below near-term support.
Despite bullish longer-term moving average structure, near-term downside risk looks higher than upside until CPSH reclaims ~5.00–5.75.
Options positioning is mixed (call-heavy open interest but put-heavy volume), suggesting uncertainty rather than a clean bullish bet.
No Intellectia proprietary edge today: AI Stock Picker and SwingMax both show no signal, so there’s no high-conviction tactical trigger to buy immediately.
Technical Analysis
Trend/Momentum: MACD histogram at -0.0842 and negatively expanding → bearish momentum building.
RSI: RSI(6) ~38.94 → drifting toward oversold but not a clear reversal signal yet.
Moving averages: SMA_5 > SMA_20 > SMA_200 → structurally bullish, but near-term momentum is contradicting that (suggests pullback within a broader uptrend).
Key levels: Current price 4.92 is below S1 (4.978) and well below pivot (5.746). Next support is S2 (4.503). Resistance overhead: ~5.75 then ~6.51.
Pattern-based short-term odds: Similar-pattern projection implies mild negative drift (next day -0.51%, next week -2.43%, next month -1.04%).
Options Data
Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio
Positioning: Extremely low put/call open interest ratio (0.03) indicates call OI dominates (bullish/levered long positioning or covered call dynamics).
Flow today: Put/call volume ratio 2.73 with small absolute volume (41 total; puts 30, calls 11) → near-term traders leaned defensive even though longer-dated OI is call-heavy.
Volatility: Very high IV (30D IV ~117.89) vs HV ~99.51; IV percentile ~45 and IV rank ~19 → elevated, but not at peak relative to its own history.
Activity spike: Today’s volume vs 30D avg 16.47x and open interest elevated vs average (120.53) → attention is high, but direction is conflicted.
Technical Summary
Sell
3
Buy
9
Positive Catalysts
suggests the broader trend can still be constructive if support holds.
Neutral/Negative Catalysts
with a -6.01% regular-session drop signals near-term weakness and poor timing for an impatient buy.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: 8,803,695, up +107.29% YoY → strong top-line acceleration.
Net income: 207,964, down -119.94% YoY → major deterioration vs prior year (suggests the prior-year quarter was meaningfully stronger and/or this quarter saw margin/expense pressure).
EPS: 0.01, down -114.29% YoY → earnings power weakened materially.
Gross margin: 17.07, down -238.56% YoY → margin compression is the key fundamental red flag; the market may demand proof of margin stabilization before re-rating.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent change: [2025-11-13] Roth Capital initiated coverage at Buy with a $6 price target.
Street pros view (bull case): Mission-critical materials exposure (aerospace/defense/industrial) and evidence of a growing commercial base; large revenue growth supports the narrative.
Street cons view (bear case): The latest quarter shows severe profitability and gross margin deterioration, which can cap upside until execution improves.
Net takeaway: Analyst tone is positive but currently outweighed by near-term technical weakness and margin-driven fundamental risk for an immediate buy.
Wall Street analysts forecast CPSH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CPSH is 6 USD with a low forecast of 6 USD and a high forecast of 6 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast CPSH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CPSH is 6 USD with a low forecast of 6 USD and a high forecast of 6 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 4.400
Low
6
Averages
6
High
6
Current: 4.400
Low
6
Averages
6
High
6
Roth Capital
NULL -> Buy
initiated
$6
AI Analysis
2025-11-13
Reason
Roth Capital
Price Target
$6
AI Analysis
2025-11-13
initiated
NULL -> Buy
Reason
Roth Capital initiated coverage of CPS Technologies with a Buy rating and $6 price target. The firm says the company manufactures high-performance materials for mission-critical applications across energy infrastructure, aerospace & defense, and industrial markets. CPS established a profitable and growing base of commercial business around several core products, the analyst tells investors in a research note.